Arginine-based cationic liposomes for efficient in vitro plasmid DNA delivery with low cytotoxicity

International Journal of Nanomedicine

Volumn 8, Issue , 2013, Pages 1361-1375

  Sarker, Satya Ranjan ^a   Aoshima, Yumiko ^a   Hokama, Ryosuke ^a   Inoue, Takafumi ^a   Sou, Keitaro ^a   Takeoka, Shinji ^a  

^a WASEDA UNIVERSITY   (Japan)

Author keywords

Cationic liposome; Counterions; Cytotoxicity; pDNA; Transfection efficiency

Indexed keywords

4 (2 HYDROXYETHYL) 1 PIPERAZINEETHANESULFONIC ACID; ARGININE; CATIONIC LIPOSOME; HYDROCHLORIC ACID; LIPOFECTAMINE; LIPOPLEX; LIPOSOME; LYSINE; PLASMID DNA; TRIFLUOROACETIC ACID; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; ATOMIC FORCE MICROSCOPY; CONTROLLED STUDY; CYTOTOXICITY TEST; DNA BINDING; FEMALE; HUMAN; HUMAN CELL; HYDRODYNAMICS; HYDROPHILICITY; IN VITRO GENE TRANSFER; LIPID ANALYSIS; LIPOSOMAL GENE DELIVERY SYSTEM; NONHUMAN; PARTICLE SIZE; PHYSICAL CHEMISTRY; RAT; TRANSMISSION ELECTRON MICROSCOPY; ZETA POTENTIAL;

CATIONIC LIPOSOME; COUNTERIONS; CYTOTOXICITY; PDNA; TRANSFECTION EFFICIENCY;

ANIMALS; ARGININE; CATIONS; CELL SURVIVAL; DNA; HELA CELLS; HUMANS; LIPOSOMES; PC12 CELLS; PLASMIDS; RATS; TRANSFECTION;

EID: 84876259197     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S38903     Document Type: Article

References (54)

1. Felgner PL, Gadek TR, Holm M, et al. Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure. Proc Natl Acad Sci U S A. 1987;84(21):7413-7417.
2. Bergen JM, Park IK, Horner PJ, Pun SH. Nonviral approaches for neuronal delivery of nucleic acids. Pharm Res. 2008;25(5):983-998.
3. Anderson WF. Human gene therapy. Nature. 1998;392(Suppl 6679): 25-30.
4. Bharali DJ, Klejbor I, Stachowiak EK, et al. Organically modified silica nanoparticles: a nonviral vector for in vivo gene delivery and expression in the brain. Proc Natl Acad Sci U S A. 2005;102(32):11539-11544.
5. Corso TD, Torres G, Goulah C, et al. Transfection of tyrosine kinase deleted FGF receptor-1into rat brain substantia nigra reduces the number of tyrosine hydroxylase expressing neurons and decreases concentration levels of striatal dopamine. Brain Res Mol Brain Res. 2005;139(2):361-366.
6. Xu Z, Yue Y, Lai Y, et al. Trans-splicing adeno-associated viral vector-mediated gene therapy is limited by the accumulation of spliced mRNA but not by dual vector coinfection efficiency. Human Gene Ther. 2004;15(9):896-905.
7. Boyce N. Trial halted after gene shows up in semen. Nature. 2001; 414(6865):677.
8. Davis SS. Biomedical applications of nanotechnology-implications for drug targeting and gene therapy. Trends Biotechnol. 1997;15(6): 217-224.
9. Li S, Tseng WC, Stolz DB, Wu SP, Watkins SC, Huang L. Dynamic changes in the characteristics of cationic lipidic vectors after exposure to mouse serum: implications for intravenous lipofection. Gene Ther. 1999;6(4):585-594.
10. Obata Y, Ciofani G, Raffa V, et al. Evaluation of cationic liposomes composed of an amino acid-based lipid for neuronal transfection. Nanomedicine. 2010;6(1):70-77.
11. Shi N, Pardridge WM. Noninvasive gene targeting to the brain. Proc Natl Acad Sci U S A. 2000;97(13):7567-7572.
12. Abdallah B, Hassan A, Benoist C, Goula D, Behr JP, Demeneix BA. A powerful nonviral vector for in vivo gene transfer into the adult mammalian brain: polyethylenimine. Human Gene Ther. 1996;7(16): 1947-1954.
13. Barati S, Chegini F, Hurtado P, Rush RA. Hybrid tetanus toxin C fragment-diphtheria toxin translocation domain allows specific gene transfer into PC12cells. Exp Neurol. 2002;177(1):75-87.
14. Usachev YM, Khammanivong A, Campbell C, Thayer SA. Particle-mediated gene transfer to rat neurons in primary culture. Pflugers Arch. 2000;439(6):730-738.
15. Xiang JJ, Tang JQ, Zhu SG, et al. IONP-PLL: a novel non-viral vector for efficient gene delivery. J Gene Med. 2003;5(9):803-817.
16. Adami RC, Seth S, Harvie P, et al. An amino acid-based amphoteric liposomal delivery system for systemic administration of siRNA. Mol Ther. 2011;19(6):1141-1151.
17. Futaki S, Ohashi W, Suzuki T, et al. Stearylated arginine-rich peptides: a new class of transfection systems. Bioconjug Chem. 2001;12(6): 1005-1011.
18. Yamanouchi D, Wu J, Lazar AN, Kent KC, Chu CC, Liu B. Biodegradable arginine-based poly(ester-amide)s as non-viral gene delivery reagents. Biomaterials. 2008;29(22):3269-3277.
19. Prata CA, Zhang XX, Luo D, McIntosh TJ, Barthelemy P, Grinstaff MW. Lipophilic peptides for gene delivery. Bioconjug Chem. 2008;19(2): 418-420.
20. Karmali PP, Kumar VV, Chaudhuri A. Design, syntheses and in vitro gene delivery efficacies of novel mono-, di-and trilysinated cationic lipids: a structure-activity investigation. J Med Chem. 2004;47(8): 2123-2132.
21. Gärtner A, Collin L, Lalli G. Nucleofection of primary neurons. Meth Enzymol. 2006;406:374-388.
22. Leclere PG, Panjwani A, Docherty R, Berry M, Pizzey J, Tonge DA. Effective gene delivery to adult neurons by a modified form of electroporation. J Neurosci Methods. 2005;142(1):137-143.
23. Behr JP, Demeneix B, Loeffler JP, Perez-Mutul J. Efficient gene transfer into mammalian primary endocrine cells with lipopolyamine-coated DNA. Proc Natl Acad Sci U S A. 1989;86(18):6982-6986.
24. Sen J, Chaudhuri A. Design, syntheses, and transfection biology of novel non-cholesterol-based guanidinylated cationic lipids. J Med Chem. 2005;48(3):812-820.
25. Choi JS, Lee EJ, Jang HS, Park JS. New cationic liposomes for gene transfer into mammalian cells with high efficiency and low toxicity. Bioconjug Chem. 2001;12(1):108-113.
26. Bajaj A, Paul B, Indi SS, Kondaiah P, Bhattacharya S. Effect of the hydrocarbon chain and polymethylene spacer lengths on gene transfection efficacies of gemini lipids based on aromatic backbone. Bioconjug Chem. 2007;18(6):2144-2158.
27. Kim WJ, Christensen LV, Jo S, et al. Cholesteryl oligoarginine delivering vascular endothelial growth factor siRNA effectively inhibits tumor growth in colon adenocarcinoma. Mol Ther. 2006;14(3):343-350.
28. Felgner JH, Kumar R, Sridhar CN, et al. Enhanced gene delivery and mechanism studies with a novel series of cationic lipid formulations. J Biol Chem. 1994;269(4):2550-2561.
29. Wasungu L, Hoekstra D. Cationic lipids, lipoplexes and intracellular delivery of genes. J Control Release. 2006;116(2):255-264.
30. Obata Y, Suzuki D, Takeoka S. Evaluation of cationic assemblies constructed with amino acid based lipids for plasmid DNA delivery. Bioconjug Chem. 2008;19(5):1055-1063.
31. Ghosh YK, Visweswariah SS, Bhattacharya S. Advantage of the ether linkage between the positive charge and the cholesteryl skeleton in cholesterol-based amphiphiles as vectors for gene delivery. Bioconjug Chem. 2002;13(2):378-384.
32. Rajesh M, Sen J, Srujan M, Mukherjee K, Sreedhar B, Chaudhuri A. Dramatic influence of the orientation of linker between hydrophilic and hydrophobic lipid moiety in liposomal gene delivery. J Am Chem Soc. 2007;129(37):11408-11420.
33. Gopal V, Prasad TK, Rao NM, Takafuji M, Rahman MM, Ihara H. Synthesis and in vitro evaluation of glutamide-containing cationic lipids for gene delivery. Bioconjug Chem. 2006;17(6):1530-1536.
34. Bajaj A, Kondiah P, Bhattacharya S. Design, synthesis, and in vitro gene delivery efficacies of novel cholesterol-based gemini cationic lipids and their serum compatibility: a structure-activity investigation. J Med Chem. 2007;50(10):2432-2442.
35. Bajaj A, Kondaiah P, Bhattacharya S. Effect of the nature of the spacer on gene transfer efficacies of novel thiocholesterol derived gemini lipids in different cell lines: a structure-activity investigation. J Med Chem. 2008;51(8):2533-2540.
36. Obata Y, Saito S, Takeda N, Takeoka S. Plasmid DNA-encapsulating liposomes: effect of a spacer between the cationic head group and hydrophobic moieties of the lipids on gene expression efficiency. Biochim Biophys Acta. 2009;1788(5):1148-1158.
37. Zhang XX, Prata CA, McIntosh TJ, Barthélémy P, Grinstaff MW. The effect of charge-reversal amphiphile spacer composition on DNA and siRNA delivery. Bioconjug Chem. 2010;21(5):988-993.
38. Sarker SR, Arai S, Murate M, et al. Evaluation of the influence of ionization states and spacers in the thermotropic phase behaviour of amino acid-based cationic lipids and the transfection efficiency of their assemblies. Int J Pharm. 2012;422(1-2):364-373.
39. Weisman S, Hirsch-Lerner D, Barenholz Y, Talmon Y. Nanostructure of cationic lipid-oligonucleotide complexes. Biophys J. 2004;87(1): 609-614.
40. Cardoso AM, Faneca H, Almeida JA, et al. Gemini surfactant dimethylene-1,2-bis(tetradecyldimethylammonium bromide)-based gene vectors: a biophysical approach to transfection efficiency. Biochim Biophys Acta. 2011;1808(1):341-351.
41. Rao NM, Gopal V. Cell biological and biophysical aspects of lipid-mediated gene delivery. Biosci Rep. 2006;26(4):301-324.
42. Almofti MR, Harashima H, Shinohara Y, Almofti A, Li W, Kiwada H. Lipoplex size determines lipofection efficiency with or without serum. Mol Membr Biol. 2003;20(1):35-43.
43. Ma B, Zhang S, Jiang H, Zhao B, Lv H. Lipoplex morphologies and their influences on transfection efficiency in gene delivery. J Control Release. 2007;123(3):184-194.
44. Kreiss P, Cameron B, Rangara R, et al. Plasmid DNA size does not affect the physicochemical properties of lipoplexes but modulates gene transfer efficiency. Nucleic Acids Res. 1999;27(19):3792-3798.
45. Ruponen M, Ylä-Herttuala S, Urtti A. Interactions of polymeric and liposomal gene delivery systems with extracellular glycosaminoglycans: physicochemical and transfection studies. Biochim Biophys Acta. 1999;1415(2):331-341.
46. Vigneron JP, Oudrhiri N, Fauquet M, et al. Guanidinium-cholesterol cationic lipids: efficient vectors for the transfection of eukaryotic cells. Proc Natl Acad Sci U S A. 1996;93(18):9682-9686.
47. Nakase I, Takeuchi T, Tanaka G, Futaki S. Methodological and cellular aspects that govern the internalization mechanisms of arginine-rich cell-penetrating peptides. Adv Drug Deliv Rev. 2008;60(4-5):598-607.
48. Yue ZG, Wei W, Lv PP, et al. Surface charge affects cellular uptake and intracellular trafficking of chitosan-based nanoparticles. Biomacromolecules. 2011;12(7):2440-2446.
49. Callaghan R, van Gorkom LC, Epand RM. A comparison of membrane properties and composition between cell lines selected and transfected for multi-drug resistance. Br J Cancer. 1992;66(5):781-786.
50. Chakravarthy BR, Spence MW, Clarke JT, Cook HW. Rapid isolation of neuroblastoma plasma membranes on Percoll gradients. Characterization and lipid composition. Biochim Biophys Acta. 1985;812(1):223-233.
51. Ruponen M, Honkakoski P, Tammi M, Urtti A. Cell-surface glycosaminoglycans inhibit cation-mediated gene transfer. J Gene Med. 2004;6(4):405-414.
52. Zuhorn IS, Hoekstra D. On the mechanism of cationic amphiphile-mediated transfection. To fuse or not to fuse: is that the question? J Membr Biol. 2002;189(3):167-179.
53. Naik RJ, Chandra P, Mann A, Ganguli M. Exogenous and cell surface glycosaminoglycans alter DNA delivery efficiency of arginine and lysine homopeptides in distinctly different ways. J Biol Chem. 2011; 286(21):18982-18993.
54. Filion MC, Phillips NC. Toxicity and immunomodulatory activity of liposomal vectors formulated with cationic lipids toward immune effector cells. Biochim Biophys Acta. 1997;1329(2):345-356.